Burel Pharmaceuticals Inc recalls

6 recalls on record

Recalls filed with 1 agency: FDA (6).

First recall on record: December 7, 2016. Most recent: December 7, 2016.

Risk classification: Class II: 6

Recalert records 6 recalls for Burel Pharmaceuticals Inc from FDA. The earliest is dated December 7, 2016 and the latest December 7, 2016. 0 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-314-10 (D-0159-2017).

Most recent recalls

Questions about this company

Does Burel Pharmaceuticals Inc have recalls in 2026?
Recalert records 0 recalls for Burel Pharmaceuticals Inc dated in 2026.

Do you carry products from Burel Pharmaceuticals Inc? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies